ÂÜÀòÂÒÂ×

Arnaud Lafforgue's most recent work experience is as the Chief Financial Officer at Oncodesign Precision Medicine (OPM) since September 2022. OPM is a technological company focused on precision medicine, with a mission to develop innovative therapeutic and diagnostic solutions for therapeutic resistance and metastasis evolution. Prior to their role at OPM, from 2018 to 2023, Arnaud served as the Group Chief Financial Officer at Oncodesign. Before that, they had various positions at Grant-Thornton France, including Director of Operational Deal Services from 2015 to 2018, Senior Manager from 2011 to 2014, and Manager from 2009 to 2011. Arnaud started their career as an Associate at Kroll Talbot Hughes from 2006 to 2009. Arnaud also has consulting experience, having worked as a Consultant at Arthur Andersen Business Consulting from 2000 to 2006 and at BearingPoint from 2000 to 2006.

Arnaud Lafforgue obtained a Master in Management with a specialization in Entrepreneurship/Entrepreneurial Studies from emlyon business school between 1998 and 2000. Prior to that, they completed a Master's degree in Finance and Economics from Université Paris Nanterre from 1992 to 1997. In 1992, Arnaud also achieved a Baccalaureat in Economics from Gerson.